block
Herzfördernde Substanzen
28 subordinate codes
XM5JS3Cardiac glycosides [No translation available]XM2PQ4Phosphodiesterase inhibitors [No translation available]XM1K71Predominantly alpha-adrenoreceptor and dopamine receptor agonists [No translation available]- Predominantly beta-adrenoreceptor agonists [No translation available]
XM7YK1Alpha acetyldigoxin [No translation available]XM0SY1b-acetyldigoxin [No translation available]XM91S1Cardiotonic (glycoside) [No translation available]XM1W74CerberinXM5NG4Ch'an su [No translation available]XM11U7Convallaria glycosides [No translation available]XM4Q19Crataegus extract [No translation available]XM7RY5Digitalin (e) [No translation available]XM2SP4Digitalis lanata [No translation available]XM3Y64Digitalis purpurea [No translation available]XM0V98Digitoxose [No translation available]XM0DG3Gitalin [No translation available]XM8K74Gitaloxin [No translation available]XM7KP5Lanatosides [No translation available]XM2X57Meproscillarin [No translation available]XM6AA6Oleandrin [No translation available]XM0N63Ouabain (e) [No translation available]XM02F5Pengitoxin [No translation available]XM77L9Squill [No translation available]XM2AW9Strophanthin [No translation available]XM0EP6Angiotensinamide [No translation available]XM45U9XamoterolXM88B5Levosimendan [No translation available]XM11H1Angiotensin II [No translation available]
Nearby in Unerwünschte Nebenwirkungen bei therapeutischer Anwendung: Primär auf das Herz-Kreislaufsystem wirkende Mittel
- Agents acting on the renin-angiotensin system [No translation available]
- Antihyperlipidemic and antiarteriosclerotic drugs [No translation available]
- Unerwünschte Nebenwirkungen bei therapeutischer Anwendung: Kalziumantagonisten
- Antiarrhythmics [No translation available]
- Other antihypertensive drugs [No translation available]
- Vasodilators used in cardiac diseases [No translation available]
- Periphere Vasodilatatoren
- Other agents primarily affecting the cardiovascular system [No translation available]